Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia

Autor: Dirk, Bassler, Eric, S Shinwell, Ikko, Hallman, Pierre-Henri, Jarreau, Richard, Plavka, Virgilio, Carnielli, Christoph, Meisner, Corinna, Engel, Alexander, Koch, Karen, Kreutzer, Johannes, N van den Anker, Matthias, Schwab, Henry, L Halliday, Christian, F Poets, Nobile, Stefano, Neonatal European Study of Inhaled Steroids Trial Group
Přispěvatelé: Pediatric Surgery, Eckstein, Anja (Beitragende*r), Felderhoff-Müser, Ursula (Beitragende*r), Hobrecht, Julia (Beitragende*r), University of Zurich, Bassler, Dirk, Clinicum, Children's Hospital, HUS Children and Adolescents
Rok vydání: 2018
Předmět:
Zdroj: New England Journal of Medicine, 378(2), 148-157. Massachussetts Medical Society
ISSN: 0028-4793
DOI: 10.1056/nejmoa1708831
Popis: Background The long-term effects on neurodevelopment of the use of inhaled glucocorticoids in extremely preterm infants for the prevention or treatment of bronchopulmonary dysplasia are uncertain. Methods We randomly assigned 863 infants (gestational age, 23 weeks 0 days to 27 weeks 6 days) to receive early (within 24 hours after birth) inhaled budesonide or placebo. The prespecified secondary long-term outcome was neurodevelopmental disability among survivors, defined as a composite of cerebral palsy, cognitive delay (a Mental Development Index score of
Databáze: OpenAIRE